Company Filing History:
Years Active: 2018
Title: Akinobu Hamada: Innovator in Monoclonal Antibody Quantification
Introduction
Akinobu Hamada is a notable inventor based in Japan. He has made significant contributions to the field of biochemistry, particularly in the quantification of monoclonal antibodies. His innovative approach has the potential to enhance the accuracy and efficiency of antibody measurement in various applications.
Latest Patents
Akinobu Hamada holds a patent titled "Method For Quantifying Monoclonal Antibody." This invention provides a method for quantifying a monoclonal antibody by bringing a porous body, which immobilizes the antibody, into contact with microparticles that have a specific protease immobilized on them. This process selectively digests the monoclonal antibody, allowing for the detection of a peptide fragment that contains amino acid residues derived from the CDR2 domain in either the heavy or light chain of the antibody.
Career Highlights
Throughout his career, Akinobu Hamada has worked with prominent organizations such as Shimadzu Corporation and the National Cancer Center. His work in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of Akinobu Hamada's notable coworkers include Takashi Shimada and Noriko Iwamoto. Their collaborative efforts have further advanced the research and development of antibody quantification methods.
Conclusion
Akinobu Hamada's contributions to the field of monoclonal antibody quantification demonstrate his innovative spirit and dedication to scientific advancement. His work has the potential to significantly impact the biochemistry landscape.